Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

Guillaume Moulis; Agnès Sommet; Johana Béné; François Montastruc; Laurent Sailler; Jean-Louis Montastruc; Maryse Lapeyre-Mestre

doi:10.1371/journal.pone.0048991

Loading metrics

Open Access

Peer-reviewed

Research Article

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

Guillaume Moulis ,

* E-mail: guillaume.moulis@univ-tlse3.fr

Affiliations CHU Toulouse, Service de Médecine Interne, Toulouse, France, CHU Toulouse, Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯
Agnès Sommet,

Affiliations CHU Toulouse, Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯
Johana Béné,

Affiliations CHU Lille, Centre Nord-Pas de Calais de PharmacoVigilance, Lille, France, Université de Lille II, Lille, France
⨯
François Montastruc,

Affiliations CHU Toulouse, Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯
Laurent Sailler,

Affiliations CHU Toulouse, Service de Médecine Interne, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯
Jean-Louis Montastruc,

Affiliations CHU Toulouse, Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯
Maryse Lapeyre-Mestre

Affiliations CHU Toulouse, Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Toulouse, France, Inserm, UMR1027, Toulouse, France, Université de Toulouse III, UMR1027, Toulouse, France
⨯

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

Guillaume Moulis,
Agnès Sommet,
Johana Béné,
François Montastruc,
Laurent Sailler,
Jean-Louis Montastruc,
Maryse Lapeyre-Mestre

Published: November 14, 2012
https://doi.org/10.1371/journal.pone.0048991

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Hematologic cancers and related disorders
Is the Subject Area "Hematologic cancers and related disorders" applicable to this article?

Thanks for your feedback.
Rheumatoid arthritis
Is the Subject Area "Rheumatoid arthritis" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.